Helleman J - Search Results

1

Molecular profiling of platinum resistant ovarian cancer.

Helleman J, Jansen MP, Span PN, van Staveren IL, Massuger LF, Meijer-van Gelder ME, Sweep FC, Ewing PC, van der Burg ME, Stoter G, Nooter K, Berns EM. Helleman J, et al. Int J Cancer. 2006 Apr 15;118(8):1963-71. doi: 10.1002/ijc.21599. Int J Cancer. 2006. PMID: 16287073 Free article.

2

Impaired cisplatin influx in an A2780 mutant cell line: evidence for a putative, cis-configuration-specific, platinum influx transporter.

Helleman J, Burger H, Hamelers IH, Boersma AW, de Kroon AI, Stoter G, Nooter K. Helleman J, et al. Cancer Biol Ther. 2006 Aug;5(8):943-9. doi: 10.4161/cbt.5.8.2876. Epub 2006 Aug 2. Cancer Biol Ther. 2006. PMID: 16775422

3

Mismatch repair and treatment resistance in ovarian cancer.

Helleman J, van Staveren IL, Dinjens WN, van Kuijk PF, Ritstier K, Ewing PC, van der Burg ME, Stoter G, Berns EM. Helleman J, et al. BMC Cancer. 2006 Jul 31;6:201. doi: 10.1186/1471-2407-6-201. BMC Cancer. 2006. PMID: 16879751 Free PMC article.

4

Gene expression profiling of treatment resistance: hype or hope for therapeutic target identification.

Helleman J, Jansen MP, Berns EM. Helleman J, et al. Int J Gynecol Cancer. 2006;16 Suppl 2:538-42. doi: 10.1111/j.1525-1438.2006.00691.x. Int J Gynecol Cancer. 2006. PMID: 17010068 Review. No abstract available.

5

Serum proteomic patterns for ovarian cancer monitoring.

Helleman J, van der Vlies D, Jansen MP, Luider TM, van der Burg ME, Stoter G, Berns EM. Helleman J, et al. Int J Gynecol Cancer. 2008 Sep-Oct;18(5):985-95. doi: 10.1111/j.1525-1438.2007.01139.x. Epub 2007 Nov 20. Int J Gynecol Cancer. 2008. PMID: 18028381

6

Downregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancer.

Jansen MP, Ruigrok-Ritstier K, Dorssers LC, van Staveren IL, Look MP, Meijer-van Gelder ME, Sieuwerts AM, Helleman J, Sleijfer S, Klijn JG, Foekens JA, Berns EM. Jansen MP, et al. Among authors: helleman j. Breast Cancer Res Treat. 2009 Jul;116(2):263-71. doi: 10.1007/s10549-008-0125-z. Epub 2008 Jul 16. Breast Cancer Res Treat. 2009. PMID: 18629630

7

Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy response.

Helleman J, Jansen MP, Ruigrok-Ritstier K, van Staveren IL, Look MP, Meijer-van Gelder ME, Sieuwerts AM, Klijn JG, Sleijfer S, Foekens JA, Berns EM. Helleman J, et al. Clin Cancer Res. 2008 Sep 1;14(17):5555-64. doi: 10.1158/1078-0432.CCR-08-0555. Clin Cancer Res. 2008. PMID: 18765548 Free article.

8

The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer.

Trinh XB, Tjalma WA, Vermeulen PB, Van den Eynden G, Van der Auwera I, Van Laere SJ, Helleman J, Berns EM, Dirix LY, van Dam PA. Trinh XB, et al. Among authors: helleman j. Br J Cancer. 2009 Mar 24;100(6):971-8. doi: 10.1038/sj.bjc.6604921. Epub 2009 Feb 24. Br J Cancer. 2009. PMID: 19240722 Free PMC article.

9

Integrated genomics of chemotherapy resistant ovarian cancer: a role for extracellular matrix, TGFbeta and regulating microRNAs.

Helleman J, Jansen MP, Burger C, van der Burg ME, Berns EM. Helleman J, et al. Int J Biochem Cell Biol. 2010 Jan;42(1):25-30. doi: 10.1016/j.biocel.2009.10.016. Epub 2009 Oct 23. Int J Biochem Cell Biol. 2010. PMID: 19854294 Review.

10

Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2).

Burger H, Zoumaro-Djayoon A, Boersma AW, Helleman J, Berns EM, Mathijssen RH, Loos WJ, Wiemer EA. Burger H, et al. Among authors: helleman j. Br J Pharmacol. 2010 Feb;159(4):898-908. doi: 10.1111/j.1476-5381.2009.00569.x. Epub 2010 Jan 8. Br J Pharmacol. 2010. PMID: 20067471 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page